Researchers at Philips have developed new technologies to improve cardiac procedures while reducing radiation exposure for patients and medical staff. At the EuroPCR 2026 conference in Paris, they will showcase innovations that combine advanced imaging, real-time guidance, and dose management to enhance procedural safety and efficiency. These technologies aim to help interventional cardiologists navigate increasingly complex procedures without compromising the quality of care.

For people undergoing cardiac procedures, these advancements could lead to safer experiences with less radiation exposure. One significant innovation, SmartIQ Technology, can reduce X-ray radiation by over 50% compared to existing low-dose settings. This means that patients may face lower risks associated with radiation while still receiving high-quality imaging during procedures. Additionally, the integration of various imaging tools allows healthcare providers to make more informed decisions in real time, which can improve outcomes for those needing coronary and structural heart interventions.

The research presented at EuroPCR 2026 is based on advanced imaging techniques and real-world applications, but it’s important to note that these technologies are still being refined and tested in clinical settings. While the results are promising, further validation through larger trials will be necessary to confirm their effectiveness and safety for widespread use. Philips aims to provide clinicians with the tools they need to deliver high-quality care while prioritizing patient safety and minimizing radiation exposure.

If you’re concerned about radiation during cardiac procedures, it may be worth discussing these new technologies with your healthcare provider. They can provide insights into how these innovations might be applied to your care and what steps are being taken to ensure your safety during treatment.

Source: globenewswire.com